Samarth Kulkarni

CIK 1682019 · Chief Executive Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.99M

Companies

6

Total Filings

110

Lifetime Open-Market Net

-$65.03M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORKA Director $69.89 $0 2 2026-06-03
CRSP Chief Executive Officer 341,123 $49.80 $16.99M -$64.02M 87 2026-03-24
CNTA Director $39.72 $0 4 2025-06-24
BDTX Director $1.75 $0 6 2025-06-12
Repare Therapeutics Inc. (RPTX) Delisted Director $2.65 $0 4 2024-06-20
CRISPR Therapeutics AG (PZRX) Delisted Chief Executive Officer 148,560 -$1.01M 7 2017-12-26

Recent Filings · Page 8 of 11

110 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-17 CRSP Mixed -$3.42M EDGAR
2021-06-03 CRSP Tax (F) −779 -$90.2K EDGAR
2021-05-14 Repare Therapeutics Inc. (RPTX) Delisted Grant (A) $0 EDGAR
2021-04-23 BDTX Grant (A) $0 EDGAR
2021-03-12 CRSP Mixed +6,307 -$686.1K EDGAR
2021-03-03 CRSP Tax (F) −798 -$103.9K EDGAR
2021-01-20 CRSP Mixed -$4.24M EDGAR
2020-12-30 CRSP Exer (M) +13,800 $25.0K EDGAR
2020-12-11 CRSP Mixed -$2.81M EDGAR
2020-12-03 CRSP Tax (F) −779 -$100.9K EDGAR
Showing 7180 of 110
Page 8 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.